Immediate Impact
52 standout
Citing Papers
Trends in the approval of cancer therapies by the FDA in the twenty-first century
2023 Standout
Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
2022 Standout
Works of I. Kührer being referenced
TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients
2015
Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| I. Kührer | 194 | 118 | 94 | 24 | 355 | |
| Philip Paul | 165 | 97 | 65 | 15 | 376 | |
| Mohammed Shaik | 137 | 64 | 184 | 19 | 384 | |
| Delphine Sénécal | 138 | 88 | 89 | 20 | 377 | |
| P. Preti | 157 | 48 | 104 | 23 | 346 | |
| Jean‐Nicolas Munck | 211 | 74 | 45 | 21 | 406 | |
| Mustafa Yaylacı | 177 | 29 | 45 | 25 | 395 | |
| G Morack | 221 | 23 | 74 | 23 | 402 | |
| Ricardo Alvarez | 129 | 34 | 72 | 19 | 361 | |
| Lavanya Yohanathan | 144 | 142 | 32 | 22 | 389 | |
| Ju‐Hee Bang | 255 | 151 | 57 | 38 | 369 |
All Works
Loading papers...